| __timestamp | Amphastar Pharmaceuticals, Inc. | Cytokinetics, Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 17268000 |
| Thursday, January 1, 2015 | 46974000 | 19667000 |
| Friday, January 1, 2016 | 47298000 | 27823000 |
| Sunday, January 1, 2017 | 50918000 | 36468000 |
| Monday, January 1, 2018 | 58044000 | 31282000 |
| Tuesday, January 1, 2019 | 63109000 | 39610000 |
| Wednesday, January 1, 2020 | 65157000 | 52820000 |
| Friday, January 1, 2021 | 68920000 | 96803000 |
| Saturday, January 1, 2022 | 66592000 | 177977000 |
| Sunday, January 1, 2023 | 80393000 | 173612000 |
Cracking the code
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Amphastar Pharmaceuticals, Inc. and Cytokinetics, Incorporated, two prominent players in the industry, have shown contrasting trends in their SG&A expenses over the past decade. From 2014 to 2023, Amphastar's SG&A costs increased by approximately 99%, while Cytokinetics saw a staggering rise of over 900%. In 2014, Amphastar's expenses were more than double those of Cytokinetics, but by 2023, Cytokinetics had surpassed Amphastar, with expenses more than twice as high. This dramatic shift highlights Cytokinetics' aggressive expansion and investment in administrative capabilities. Meanwhile, Amphastar's steady growth reflects a more conservative approach. Understanding these trends provides valuable insights into each company's strategic priorities and operational efficiencies.
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Cytokinetics, Incorporated
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Cytokinetics, Incorporated
Who Optimizes SG&A Costs Better? Genmab A/S or Cytokinetics, Incorporated
Breaking Down SG&A Expenses: Grifols, S.A. vs Amphastar Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
Alkermes plc vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Vericel Corporation vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Comparing SG&A Expenses: HUTCHMED (China) Limited vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Selling, General, and Administrative Costs: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Amphastar Pharmaceuticals, Inc. and Evotec SE